GLP-1 Analogues Market

The GLP-1 analogues market encompasses a class of medications that mimic a natural hormone to regulate blood sugar and appetite. These drugs primarily serve patients with type 2 diabetes and, more recently, those with obesity. Key growth drivers include the rising global prevalence of these chronic conditions, significant advancements in healthcare infrastructure, and the expansion of treatment accessibility through online channels.